Amneal Pharmaceuticals【AMRX】銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

8.3013

買値

8.40

売値

8.68

出来高

1,499,840

8.37 日の範囲 9.01

5.01 52 週間の範囲 9.475

時価総額

2.57B

前日終値

9.00

始値

9.00

時刻

8.43

最終取引時間

財務取引量

US$ 12,918,739

VWAP

8.6134

平均取引量 (3 か月)

1,129,003

発行済株式数

309,542,608

配当利回り

PER

-21.64

1 株当たり利益 (EPS)

-0.27

歳入

2.41B

純利益

-83.99M

Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inha... Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. 詳細を表示

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.amneal.com

本社

Wilmington, Delaware, USA

設立

Amneal Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker AMRX. The last closing price for Amneal Pharmaceuticals was US$9. Over the last year, Amneal Pharmaceuticals shares have traded in a share price range of US$ 5.01 to US$ 9.475.

Amneal Pharmaceuticals currently has 309,542,608 shares in issue. The market capitalisation of Amneal Pharmaceuticals is US$2.79 billion. Amneal Pharmaceuticals has a price to earnings ratio (PE ratio) of -21.64.

全体の流れ

ベアリッシュ

ネットプレミアム

-35k

Calls / Puts

0.00%

買い / 売り

100.00%

OTM / ITM

100.00%

Sweeps比率

Amneal and Metsera Announce Strategic Collaboration to Develop and Supply Portfolio of Next-Generation Medicines for Obesity and Metabolic Diseases

Amneal to construct state-of-the-art manufacturing facilities and utilize existing manufacturing network to ensure supply of Metsera’s portfolio of novel injectable and oral development programs...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.1513	1.85644171779	8.15	9.475	7.52	1565515	9.04763758	CS
4	-0.1587	-1.87588652482	8.46	9.475	7.52	1097564	8.6803261	CS
12	0.1913	2.3588162762	8.11	9.475	7.52	1129003	8.59494558	CS
26	1.4513	21.1868613139	6.85	9.475	6.29	1246685	7.7325316	CS
52	2.4213	41.1785714286	5.88	9.475	5.01	1373634	6.80117871	CS
156	2.4213	41.1785714286	5.88	9.475	5.01	1373634	6.80117871	CS
260	2.4213	41.1785714286	5.88	9.475	5.01	1373634	6.80117871	CS

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
CEROCERo Therapeutics Holdings Inc	US$ 0.2853 (52.40%)	1.17B
CYCNCyclerion Therapeutics Inc	US$ 2.5306 (42.97%)	11.99M
SPPLSIMPPLE Ltd	US$ 1.2503 (41.60%)	165.69M
PULMPulmatrix Inc	US$ 6.5586 (39.54%)	5.37M
ZTEKZentek Ltd	US$ 1.2574 (29.96%)	309.67k
TFFPTFF Pharmaceuticals Inc	US$ 0.376101 (-76.49%)	9.23M
EYENEyenovia Inc	US$ 0.10185 (-70.05%)	51.98M
CTXRCitius Pharmaceuticals Inc	US$ 0.1974 (-39.89%)	11.15M
VVPRVivoPower International PLC	US$ 0.8151 (-39.62%)	2.3M
IPWiPower Inc	US$ 0.7302 (-39.15%)	1.13M
CEROCERo Therapeutics Holdings Inc	US$ 0.2853 (52.40%)	1.15B
ELABElevai Labs Inc	US$ 0.0211 (-19.47%)	377.69M
NVDANVIDIA Corporation	US$ 141.98 (-3.26%)	244.07M
SPPLSIMPPLE Ltd	US$ 1.2503 (41.60%)	164.49M
STISolidion Technology Inc	US$ 0.44 (25.71%)	139.46M